Federal Register Correction: In Title 21 of the Code of Federal Regulations, Parts 500 to 599, revised as of 4/1/11, on page 96, in Sec. 516.20, (b)(2) is revised to read as follows: Sec. 516.20 Content and format of a request for MUMS-drug designation.* * * * * (b) * * * (2) The name and address of the sponsor; the name of the sponsor’s primary contact person and/or permanent-resident U.S. agent including title, address, and telephone number; the established name (and proprietary name, if any) of the active pharmaceutical ingredient of the drug; and the name and address of the source of the active pharmaceutical ingredient of the drug. To view this correction, click here.